Robin Hood Ventures

Robin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. Robin Hood generally invests $250k to $500k, and collaborates with angels, institutions and VCs in our network. We invest as a single entity in businesses we know and understand, in a way that gets deals done. Since 1999, we have invested in over 45 companies in industries including software, medical devices, biotech, internet and financial technology.

Donna Cordner

Managing Partner

Allen Fogel

Partner

Sasha Schrode

Partner at Robin Hood Ventures

Ellen Weber

Executive Director

151 past transactions

Integrated Reality Labs

Funding Round in 2025
Integrated Reality Labs (IRL Inc.) builds integrated reality (IR) games and tools that enhance play in the real world. Our patent pending Integrated Reality Technology Platform leverages UWB, bluetooth + mobile location services & other device sensors to power all of IRL’s products, starting with SLAP. SLAP is a mobile app that digitally transforms IRL games - like Assassin, HvZ, Capture the Flag, Manhunt & Tag - making them more fun and easier to play anytime, anywhere, and with anyone. IRL inc is in the process of using the IRTP to empower end users to create, share, and monetize their own mobile powered real world games... a la the Roblox if IRL Games.

Vessl Prosthetics

Pre Seed Round in 2025
Vessl Prosthetics is a prosthetics firm that is driven by the idea of empowering amputees and their champions to overcome challenges and realize their full potential. The objective is to revolutionize how amputees engage with prosthetic devices by developing new, inexpensive, and accessible alternatives.

BrilliantPad

Funding Round in 2024
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents.

Virion Therapeutics

Funding Round in 2024
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Vytala

Pre Seed Round in 2024
Vytala is a food tech firm focused on improving nutrition through innovative solutions.

Accencio

Funding Round in 2024
Accencio is an intellectual property strategy and intelligence company. It provides visualized intellectual property strategy and intelligence for molecular-based industry and research. It offers unique, interactive visualizations and analysis to the customers.

Ophidion

Funding Round in 2024
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

Fuego

Funding Round in 2024
Fuego is a global dance-inspired athleisure and lifestyle brand that specializes in the design and manufacture of innovative footwear. The company offers a line of patented sneakers engineered for both dancing and everyday wear, featuring sole technology that supports movement on various surfaces. Fuego's sneakers are lightweight, shock-absorbing, flexible, and built with a minimalistic design. They are also vegan, spill-proof, and water-resistant, catering to the needs of dancers and fitness enthusiasts alike. Fuego's products are endorsed by top dancers worldwide and have been showcased in collaborations with notable figures in the dance community. With a presence in 120 countries, the brand aims to blend functionality with style, allowing users to seamlessly transition from the street to the dance studio.

Epoxy.ai

Funding Round in 2024
Epoxy.ai is a technology developer specializing in sports personalization solutions that cater to media and gaming companies. The company offers tools that utilize artificial intelligence and machine learning to provide contextually relevant data, enhancing customer acquisition, engagement, and retention. Through its suite of licensable, easily integrated application programming interfaces (APIs) and plug-and-play components, Epoxy.ai enables clients to automate complex workflows and gain actionable insights into customer behavior across various touchpoints. This technology supports sports leagues, betting companies, and media entities in effectively connecting with their audiences and evolving their strategies within the global sports media and gaming industry.

S2N Health

Seed Round in 2024
S2N Health is a consulting firm that specializes in providing strategy consulting services and SaaS solutions tailored for the medical technology sector. Established in 2011, the company has worked with over 160 organizations, ranging from startups to large multinational firms, offering insights and analytics that inform critical product, commercial, and business decisions. S2N Health supports clients across various stages, including product development, market entry, sales acceleration, and strategic partnerships. A key offering is RepSignal, an AI-driven SaaS solution launched in 2022, which provides medtech commercial teams with on-demand customer insights and intelligence, allowing them to effectively target and engage clinical customers. The firm aims to facilitate the growth and success of medical technology innovators by leveraging a network of experts in regulatory, reimbursement, and other relevant disciplines.

FEMSelect

Convertible Note in 2024
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.

BiologicsMD

Corporate Round in 2024
BiologicsMD, Inc. is a therapeutic development company based in Fayetteville, Arkansas, established in 2010. The company specializes in creating targeted therapies for hair loss and severe bone disorders. Its product pipeline includes BMD-1141, a hair cycle stimulator aimed at restoring normal hair growth and preventing hair loss by stimulating the hair cycle, and BMD-1231, a bone graft substitute designed for spinal fusion procedures. BiologicsMD focuses on developing recombinant fusion proteins that deliver potent stimulatory effects directly to specific receptors at the site of disease, allowing for sustained therapeutic exposure with either a single dose or infrequent dosing regimens. The company is also exploring various formulation and delivery methods for parenteral, local, and topical administration of its therapies.

Burrow

Convertible Note in 2024
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Deepwave Digital

Convertible Note in 2024
Deepwave Digital, Inc. specializes in manufacturing artificial intelligence (AI)-based hardware and software solutions tailored for radio frequency (RF) and wireless systems. Established in 2017 and headquartered in Philadelphia, Pennsylvania, the company provides integrated solutions that enhance the capabilities of RF systems by relocating the AI computation engine closer to the signal edge. This innovative approach minimizes network bandwidth usage, reduces latency, and decreases reliance on manual analysis. Deepwave Digital's product lineup includes the Artificial Intelligence Radio Transceiver (AIR-T), a software-defined radio, as well as software tools like AirPack, AirStack Sandbox, and Spectrum Sensing, which help clients detect and identify signals in their spectral environment. With a team of RF industry experts boasting over fifty years of combined experience, Deepwave Digital serves both commercial and defense sectors, enabling customers to develop custom AI and high-performance computing systems using trusted software solutions.

Proscia

Series C in 2024
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Biomeme

Convertible Note in 2024
Biomeme Inc., founded in 2012 and based in Philadelphia, Pennsylvania, offers an innovative platform for molecular DNA diagnostics and on-site disease tracking through a smartphone. The company's technology includes a real-time PCR thermocycler that connects to an iPhone, alongside a docking station and a mobile app for controlling the system and analyzing results. Biomeme provides targeted test kits that allow users to prepare samples and identify pathogens or diseases based on their specific DNA or RNA signatures. This end-to-end DNA testing solution enables mobile testing at the point-of-need across various sectors, including healthcare, agriculture, veterinary medicine, environmental monitoring, and education. By facilitating lab-grade molecular processes, Biomeme enhances real-time disease surveillance and diagnostics.

GABA Therapeutics

Funding Round in 2024
GABA Therapeutics is focused on developing GRX-917, a medication designed for the treatment of anxiety, depression, and various neuropsychiatric and neurological disorders. This drug features a dual mechanism of action, offering a rapid onset of effects similar to benzodiazepines while minimizing side effects. By targeting a wide range of conditions, GABA Therapeutics aims to provide effective relief for patients suffering from life-altering neuropsychiatric, neurologic, and pain disorders.

OcuTerra Therapeutics

Convertible Note in 2024
OcuTerra Therapeutics, Inc. is focused on developing innovative therapies for ophthalmic diseases that currently lack effective treatment options. The company is working on a novel eye drop specifically designed to address diabetic eye disease. This eye drop functions as an integrin inhibitor and is engineered to reach the back of the eye, allowing healthcare professionals to better assist patients in preventing vision loss associated with this condition. Through its advancements, OcuTerra aims to improve outcomes for individuals suffering from serious eye diseases.

Vesteck

Convertible Note in 2024
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

BrilliantPad

Convertible Note in 2024
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents.

Illumina Radiopharmaceuticals

Venture Round in 2023
Illumina Radiopharmaceuticals

Medcura

Convertible Note in 2023
Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

SessionGuardian

Seed Round in 2023
SessionGuardian is the market pioneer in identity access control and authentication for hybrid teams working with extremely sensitive data.

Fuego

Convertible Note in 2023
Fuego is a global dance-inspired athleisure and lifestyle brand that specializes in the design and manufacture of innovative footwear. The company offers a line of patented sneakers engineered for both dancing and everyday wear, featuring sole technology that supports movement on various surfaces. Fuego's sneakers are lightweight, shock-absorbing, flexible, and built with a minimalistic design. They are also vegan, spill-proof, and water-resistant, catering to the needs of dancers and fitness enthusiasts alike. Fuego's products are endorsed by top dancers worldwide and have been showcased in collaborations with notable figures in the dance community. With a presence in 120 countries, the brand aims to blend functionality with style, allowing users to seamlessly transition from the street to the dance studio.

Simply Good Jars

Convertible Note in 2023
Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everyday operations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.

Epoxy.ai

Seed Round in 2023
Epoxy.ai is a technology developer specializing in sports personalization solutions that cater to media and gaming companies. The company offers tools that utilize artificial intelligence and machine learning to provide contextually relevant data, enhancing customer acquisition, engagement, and retention. Through its suite of licensable, easily integrated application programming interfaces (APIs) and plug-and-play components, Epoxy.ai enables clients to automate complex workflows and gain actionable insights into customer behavior across various touchpoints. This technology supports sports leagues, betting companies, and media entities in effectively connecting with their audiences and evolving their strategies within the global sports media and gaming industry.

Wavely Diagnostics

Seed Round in 2023
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Verdafresh

Series B in 2023
Verdafresh specializes in flexible packaging solutions that preserve the freshness of food while emphasizing recyclability. The company manufactures mono-material packaging that incorporates barrier coatings on films, providing an effective alternative to traditional materials like EVOH. This innovative approach not only helps extend the shelf life of food products but also addresses concerns related to plastic waste. By focusing on natural and abundant materials, Verdafresh aims to deliver competitive and sustainable packaging options for its clients, ensuring both quality preservation and environmental responsibility.

Ophidion

Convertible Note in 2023
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

ChargeItSpot

Series A in 2023
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.

Hanimune Therapeutics

Seed Round in 2023
Hanimune Therapeutics is a biotechnology company that seeks to prevent and treat food allergies by using nature-based solutions. It is also developing novel treatments for food allergies that utilize the tolerogenic immune system, which is part of the immune system that prevents harmful reactions to harmless substances.

Measure Studio

Seed Round in 2023
Measure Studio operates a content intelligence engine that aids users in developing data-driven social media strategies. The platform serves digital publishers, brands, agencies, and influencers by providing a secure environment to consolidate and analyze social media data. By facilitating better management of social media analytics across various platforms, Measure Studio empowers its users to create more effective and engaging content based on insights derived from their data.

Cooler Heads

Venture Round in 2023
Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Lia

Convertible Note in 2023
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

LUXTECH

Convertible Note in 2023
LUXTECH, LLC is a Philadelphia-based company that specializes in designing, engineering, and manufacturing LED module solutions for lighting fixture manufacturers. Established in 2012, the company focuses on specification-grade LED modules, which include a range of products such as LINEAR Dynamic White, COB Warm Dim, and FLEX LED modules. LUXTECH caters to various industries, including entertainment, education, healthcare, and cultural sectors, by providing modules that support human-centric architectural lighting applications. The company assists original equipment manufacturers (OEMs) in rapidly developing reliable, energy-efficient LED fixtures to meet market demands. With a commitment to innovation and efficiency, LUXTECH also offers custom designs and consultation services, enabling partners to retrofit existing fixtures or create new ones. Their products are designed for diverse applications such as troffers, downlights, and outdoor lighting, featuring long lifetimes and low energy consumption. LUXTECH’s LED modules are built using high-quality components, backed by a five-year warranty, ensuring reliability and performance in the lighting industry.

Vesteck

Venture Round in 2023
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

Beckon Ice cream

Seed Round in 2022
Beckon Ice Cream specializes in producing premium lactose-free ice cream made from real milk and cream. The company utilizes lactase enzyme to ensure its products are suitable for lactose-intolerant consumers. Beckon’s ice cream is crafted with only six natural ingredients, avoiding any gums, stabilizers, or artificial additives. The product line includes a variety of flavors, such as vanilla, mint chip, sea salt chocolate chip, peanut butter cup, and dark chocolate brownie, available in formats like pints and quarts. By focusing on clean-label products, Beckon caters to those seeking quality dairy alternatives without compromising on flavor.

Fuego

Seed Round in 2022
Fuego is a global dance-inspired athleisure and lifestyle brand that specializes in the design and manufacture of innovative footwear. The company offers a line of patented sneakers engineered for both dancing and everyday wear, featuring sole technology that supports movement on various surfaces. Fuego's sneakers are lightweight, shock-absorbing, flexible, and built with a minimalistic design. They are also vegan, spill-proof, and water-resistant, catering to the needs of dancers and fitness enthusiasts alike. Fuego's products are endorsed by top dancers worldwide and have been showcased in collaborations with notable figures in the dance community. With a presence in 120 countries, the brand aims to blend functionality with style, allowing users to seamlessly transition from the street to the dance studio.

FEMSelect

Series B in 2022
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.

Epoxy.ai

Venture Round in 2022
Epoxy.ai is a technology developer specializing in sports personalization solutions that cater to media and gaming companies. The company offers tools that utilize artificial intelligence and machine learning to provide contextually relevant data, enhancing customer acquisition, engagement, and retention. Through its suite of licensable, easily integrated application programming interfaces (APIs) and plug-and-play components, Epoxy.ai enables clients to automate complex workflows and gain actionable insights into customer behavior across various touchpoints. This technology supports sports leagues, betting companies, and media entities in effectively connecting with their audiences and evolving their strategies within the global sports media and gaming industry.

AnaOno

Seed Round in 2022
AnaOno is an apparel brand focused on creating unique intimates and loungewear for women who have undergone breast surgery, including mastectomies and breast reconstructions, often due to cancer diagnoses. The company designs its products to accommodate different breast shapes and surgical needs, crafting wire-free undergarments made from soft materials that prioritize comfort. With an emphasis on feminine details and diverse silhouettes, AnaOno offers a range of options to meet the specific needs of women living with these conditions, ensuring they have access to stylish and functional apparel.

SessionGuardian

Seed Round in 2022
SessionGuardian is the market pioneer in identity access control and authentication for hybrid teams working with extremely sensitive data.

Medcura

Venture Round in 2022
Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

Thermalin

Venture Round in 2022
Thermalin, Inc. is a biotechnology company based in Cleveland, Ohio, founded in 2010, that specializes in developing innovative insulin therapies for individuals with Type 1 and Type 2 diabetes. The company aims to disrupt the insulin and insulin delivery market with its first-in-class, ultra-rapid acting insulin, which is stabilized and highly concentrated. This new insulin formulation is designed for use in a disposable, postage-stamp-sized glucose management system and can also be utilized in existing insulin pumps. In addition to its lead program, Thermalin is exploring partnerships to develop no-cold-chain basal and mix insulins, as well as glucose-responsive insulins. By creating insulin analogs that do not require refrigeration and are rapidly absorbed, Thermalin seeks to reduce the burden of insulin therapy, thereby improving patient adherence and health outcomes.

Illumina Radiopharmaceuticals

Venture Round in 2022
Illumina Radiopharmaceuticals

BiologicsMD

Venture Round in 2022
BiologicsMD, Inc. is a therapeutic development company based in Fayetteville, Arkansas, established in 2010. The company specializes in creating targeted therapies for hair loss and severe bone disorders. Its product pipeline includes BMD-1141, a hair cycle stimulator aimed at restoring normal hair growth and preventing hair loss by stimulating the hair cycle, and BMD-1231, a bone graft substitute designed for spinal fusion procedures. BiologicsMD focuses on developing recombinant fusion proteins that deliver potent stimulatory effects directly to specific receptors at the site of disease, allowing for sustained therapeutic exposure with either a single dose or infrequent dosing regimens. The company is also exploring various formulation and delivery methods for parenteral, local, and topical administration of its therapies.

Proscia

Series C in 2022
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Atrin Pharmaceuticals

Venture Round in 2022
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of innovative cancer treatments. Founded in 2011, the company is developing its lead drug candidates, ATRN-502, a p53 activator, and ATRN-507, a dual ligand that selectively targets cancer cells. Atrin is also advancing a proprietary platform called Atrize, which utilizes phenotypic FACS-based screening for rapid identification of effective drug candidates and evaluation of personalized medicine approaches. The company's research aims to address cancers linked to synthetic lethality and deregulated DNA damage response, with a focus on creating treatments that are effective against cancer cells while minimizing impact on healthy cells. Through its innovative methodologies, Atrin Pharmaceuticals seeks to change the landscape of cancer therapy.

ChargeItSpot

Venture Round in 2022
ChargeItSpot, LLC offers cell phone charging stations and kiosks across the United States and Canada. Founded in 2011 and headquartered in Philadelphia, Pennsylvania, the company provides free and secure charging solutions that enhance customer engagement in various locations, including retail stores, malls, casinos, stadiums, hospitals, and at events such as conferences and festivals. ChargeItSpot's stations are equipped with a touchscreen interface, secure locking capability, and customizable on-screen messages, as well as features for data tracking and reporting. These charging stations not only serve the practical need for device charging but are also designed to increase sales and customer traffic, making them a valuable asset for brands and retailers.

Vertiq

Series B in 2022
Vertiq specializes in high-performance propulsion solutions for aerial vehicles and mobile robots. The company designs ultra-compact, integrated motors and electronic speed controllers (ESC) that feature embedded position sensors. These innovations, combined with advanced motor calibration and control software, provide vehicles with significant performance enhancements, such as extended flight times, improved maneuverability, and increased reliability. By optimizing motor performance and controllability, Vertiq enables its clients to elevate the capabilities of their vehicles, making them suitable for a range of applications in various industries.

Simply Good Jars

Seed Round in 2022
Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everyday operations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.

Burrow

Series C in 2022
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Lia

Seed Round in 2022
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

Beckon Ice cream

Seed Round in 2022
Beckon Ice Cream specializes in producing premium lactose-free ice cream made from real milk and cream. The company utilizes lactase enzyme to ensure its products are suitable for lactose-intolerant consumers. Beckon’s ice cream is crafted with only six natural ingredients, avoiding any gums, stabilizers, or artificial additives. The product line includes a variety of flavors, such as vanilla, mint chip, sea salt chocolate chip, peanut butter cup, and dark chocolate brownie, available in formats like pints and quarts. By focusing on clean-label products, Beckon caters to those seeking quality dairy alternatives without compromising on flavor.

Cooler Heads

Seed Round in 2021
Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

BrilliantPad

Series D in 2021
BrilliantPet introduces smart self-cleaning dog potty. The product is an automatic, convenient and self-cleaning indoor waste disposal product for dogs. They provide a more convenient and healthier potty solution that brings peace of mind to dogs and pet parents.

Vesteck

Series A in 2021
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.

Medcura

Series A in 2021
Medcura, Inc. specializes in developing advanced hemostatic and wound care products applicable in surgical, military, medical, and consumer settings. The company markets its offerings under various brand names, including R3, Medcura Flex, LifeFoam, and Surgicura. Founded in 2007 and based in Riverdale, Maryland, Medcura transforms abundant natural materials into innovative solutions for effectively managing high-impact surgical bleeds. Its product range not only focuses on controlling bleeding but also includes antibacterial barriers that enhance healing environments. Medcura's versatile platform is designed to meet the needs of a wide array of clinical and non-clinical scenarios, enabling healthcare professionals to improve patient outcomes.

OcuTerra Therapeutics

Series B in 2021
OcuTerra Therapeutics, Inc. is focused on developing innovative therapies for ophthalmic diseases that currently lack effective treatment options. The company is working on a novel eye drop specifically designed to address diabetic eye disease. This eye drop functions as an integrin inhibitor and is engineered to reach the back of the eye, allowing healthcare professionals to better assist patients in preventing vision loss associated with this condition. Through its advancements, OcuTerra aims to improve outcomes for individuals suffering from serious eye diseases.

Intrommune Therapeutics

Series A in 2021
Intrommune Therapeutics is a clinical-stage biotechnology company focused on developing safe and effective treatments for food allergies. The company’s Oral Mucosal Immunotherapy (OMIT) platform utilizes a specially formulated toothpaste that allows patients to safely expose their immune systems to allergenic proteins while maintaining oral hygiene. The primary product under development, INT301, targets peanut allergy, addressing a significant unmet need in a market with limited treatment options. Currently, only one FDA-approved product for food allergies exists, which requires patients to ingest peanut protein, a method that many find difficult and risky. Intrommune's innovative approach aims to provide a more accessible and manageable solution for patients and their families, reducing the fear associated with food allergies. The company is conducting a Phase 1b study for INT301, with important developmental milestones expected in the coming year.

Sonnest

Series A in 2021
Sonnest is a clinical healthcare company focused on myocardium-related solutions. It specializes in developing an electrically sensitive imaging agent that assesses and monitors the heart's perfusion, structure, and function. This innovative agent activates through ultrasound and responds to the heart's local electric field, indicating the viability of heart tissue. By providing advanced imaging technology, Sonnest aims to enhance patient care and clinical outcomes. The company addresses customer inquiries through various channels, including phone, email, and online applications, ensuring comprehensive support for healthcare professionals.

Deepwave Digital

Seed Round in 2020
Deepwave Digital, Inc. specializes in manufacturing artificial intelligence (AI)-based hardware and software solutions tailored for radio frequency (RF) and wireless systems. Established in 2017 and headquartered in Philadelphia, Pennsylvania, the company provides integrated solutions that enhance the capabilities of RF systems by relocating the AI computation engine closer to the signal edge. This innovative approach minimizes network bandwidth usage, reduces latency, and decreases reliance on manual analysis. Deepwave Digital's product lineup includes the Artificial Intelligence Radio Transceiver (AIR-T), a software-defined radio, as well as software tools like AirPack, AirStack Sandbox, and Spectrum Sensing, which help clients detect and identify signals in their spectral environment. With a team of RF industry experts boasting over fifty years of combined experience, Deepwave Digital serves both commercial and defense sectors, enabling customers to develop custom AI and high-performance computing systems using trusted software solutions.

Beckon Ice cream

Angel Round in 2020
Beckon Ice Cream specializes in producing premium lactose-free ice cream made from real milk and cream. The company utilizes lactase enzyme to ensure its products are suitable for lactose-intolerant consumers. Beckon’s ice cream is crafted with only six natural ingredients, avoiding any gums, stabilizers, or artificial additives. The product line includes a variety of flavors, such as vanilla, mint chip, sea salt chocolate chip, peanut butter cup, and dark chocolate brownie, available in formats like pints and quarts. By focusing on clean-label products, Beckon caters to those seeking quality dairy alternatives without compromising on flavor.

Beckon

Venture Round in 2020
Beckon, Inc. offers omnichannel analytics software designed to provide marketers with performance analytics, visualization, and reporting solutions. Founded in 2011 and based in San Mateo, California, the company operates as a subsidiary of Aclate, Inc. Beckon's software-as-a-service platform integrates marketing data to deliver dashboards and scorecards that facilitate cross-channel marketing intelligence. The platform emphasizes data management and visibility into marketing performance, enabling users to analyze their campaigns in real time. It provides automated tools for campaign planning and offers key performance indicators to help marketers optimize their strategies, maximize return on investment, and demonstrate the impact of marketing efforts on overall business outcomes.

FEMSelect

Convertible Note in 2020
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.

Cooler Heads

Convertible Note in 2020
Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Proscia

Series B in 2020
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Wash Cycle Laundry

Series A in 2020
Wash Cycle Laundry will pick up your dirty laundry on a bike and bring it back clean tomorrow. Cleaning clothes can be a dirty business. They use eco-friendly "free and clear" laundry detergents for all their wash-and-fold, and only non-perc solvents for all their dry cleaning. Most standard dry cleaners use "PERC" in their dry cleaning process, which the State of California believes to be a carcinogen. Founded in 2010 and headquartered in Philadelphia, Pennsylvania.

ExpressCells

Venture Round in 2020
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers. ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.

Thermalin

Convertible Note in 2020
Thermalin, Inc. is a biotechnology company based in Cleveland, Ohio, founded in 2010, that specializes in developing innovative insulin therapies for individuals with Type 1 and Type 2 diabetes. The company aims to disrupt the insulin and insulin delivery market with its first-in-class, ultra-rapid acting insulin, which is stabilized and highly concentrated. This new insulin formulation is designed for use in a disposable, postage-stamp-sized glucose management system and can also be utilized in existing insulin pumps. In addition to its lead program, Thermalin is exploring partnerships to develop no-cold-chain basal and mix insulins, as well as glucose-responsive insulins. By creating insulin analogs that do not require refrigeration and are rapidly absorbed, Thermalin seeks to reduce the burden of insulin therapy, thereby improving patient adherence and health outcomes.

Yellowdig

Convertible Note in 2020
Yellowdig is a software platform that enhances peer learning outcomes by creating a social layer on top of existing enterprise learning systems utilized by colleges, universities, and organizations. Established in 2015 and based in Philadelphia, Pennsylvania, Yellowdig focuses on providing a private and secure experience tailored for higher education institutions. The platform fosters collaborative learning environments, encouraging student engagement and retention while enhancing their understanding of current affairs. By integrating with established learning systems, Yellowdig transforms traditional classrooms into vibrant learning communities.

Simply Good Jars

Convertible Note in 2020
Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everyday operations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.

Biomeme

Convertible Note in 2020
Biomeme Inc., founded in 2012 and based in Philadelphia, Pennsylvania, offers an innovative platform for molecular DNA diagnostics and on-site disease tracking through a smartphone. The company's technology includes a real-time PCR thermocycler that connects to an iPhone, alongside a docking station and a mobile app for controlling the system and analyzing results. Biomeme provides targeted test kits that allow users to prepare samples and identify pathogens or diseases based on their specific DNA or RNA signatures. This end-to-end DNA testing solution enables mobile testing at the point-of-need across various sectors, including healthcare, agriculture, veterinary medicine, environmental monitoring, and education. By facilitating lab-grade molecular processes, Biomeme enhances real-time disease surveillance and diagnostics.

Genome Profiling

Convertible Note in 2020
Genome Profiling, LLC (www.genprollc.com) is at the forefront of this rapidly emerging market with the first epigenetic biomarker discovery platform that combines a proprietary pre-NGS gDNA preparation kit matched to powerful NGS data analytics algorithms that plug-n-play into standard NGS workflows and enable one NGS run to deliver data for both genomic variant call analyses data AND epigenetic data.

ReturnLogic

Seed Round in 2020
ReturnLogic is a developer of a cloud-based returns management platform designed to transform the returns process for retailers. By leveraging artificial intelligence and an API-first approach, the platform automates workflows for customer service and warehouse teams, facilitating an easy returns process for both warranty requests and general returns. This innovative solution addresses the challenges of retail returns, providing visibility and optimization that allow e-commerce retailers and brands to enhance productivity and improve their bottom-line growth. ReturnLogic aims to turn returns from a cumbersome task into a strategic asset for businesses in the retail sector.

LoanLogics

Convertible Note in 2020
LoanLogics, Inc. is a provider of mortgage loan software and services aimed at enhancing the efficiency and quality of the mortgage industry. The company offers a range of products, including LoanDecisions, which focuses on product eligibility and pricing, and LoanHD, a platform dedicated to real-time loan quality management. Their solutions are designed to help residential mortgage lenders, servicers, insurers, and investors automate processes, thereby reducing loan defects, cutting costs, and minimizing risks associated with loan transactions. LoanLogics also features a loan performance management platform and an on-demand service ordering solution that connects lenders with third-party providers. With a commitment to advancing digital transformation in the mortgage sector, LoanLogics emphasizes compliance and performance accuracy in its offerings. Established in 2006 and based in Trevose, Pennsylvania, the company was formerly known as Aklero Risk Analytics, Inc. and rebranded in 2013.

FEMSelect

Convertible Note in 2020
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.

Burrow

Series B in 2020
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

OWIT Global

Series A in 2020
OWIT Global is a provider of innovative insurance technology solutions aimed at enhancing and future-proofing insurance processing. Founded in 2018 and headquartered in West Hartford, Connecticut, the company specializes in offering a range of cloud-based microservices tailored for the global insurance industry. These microservices can function independently or integrate seamlessly with existing systems, allowing for flexible and targeted solutions. OWIT Global’s offerings include Bordereaux Management, Cyber Rating & Distribution, Accident & Health and Specialty Point of Sale, Document Generation, and Portal Configuration, among others. The company's platform facilitates data ingestion and transformation, supporting the insurance industry's evolving needs and the integration of emerging technologies such as blockchain and smart contracts.

Immunome

Series A in 2020
Immunome Inc. is a biotechnology company based in Exton, Pennsylvania, specializing in the discovery and development of human cancer antibodies that target universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that effectively target these antigens. Additionally, Immunome employs its ScreenMab technology for multiplex functional screening, which focuses on monoclonal antibodies with high specificity for tumor neoantigens. Founded in 2006, Immunome is dedicated to advancing immunotherapy through its innovative approaches in antigen discovery and antibody development.

Lia

Convertible Note in 2020
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

AgileSwitch

Venture Round in 2020
AgileSwitch plug and play drivers were designed from the ground up to address these challenges and the drivers are among the most efficient and reliable in the market. Furthermore, AgileSwitch drivers can be fully customized to meet the needs and demands of virtually any customer application. With an ongoing product development commitment, AgileSwitch is continuously expanding the product line of gate drivers.

Annovis Bio

Post in 2020
Annovis Bio, Inc. is a clinical-stage pharmaceutical company based in Berwyn, Pennsylvania, specializing in the development of treatments for neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease. The company is advancing several compounds in clinical trials, with its lead candidate, ANVS401, currently in Phase 2a trials aimed at treating Alzheimer’s disease, Parkinson’s disease, and other chronic neurodegenerative conditions. Additionally, Annovis is developing ANVS405, which focuses on providing neuroprotection following traumatic brain injuries and strokes, and ANVS301, which is in Phase I trials designed to enhance cognitive function in later stages of Alzheimer’s disease and dementia. Founded in 2008, Annovis Bio is dedicated to creating innovative therapies to address the challenges posed by these debilitating diseases.

Virion Therapeutics

Convertible Note in 2019
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Immunome

Series A in 2019
Immunome Inc. is a biotechnology company based in Exton, Pennsylvania, specializing in the discovery and development of human cancer antibodies that target universal cancer antigens. The company utilizes its proprietary RealMAb technology to identify novel antigens and the corresponding native human antibodies that effectively target these antigens. Additionally, Immunome employs its ScreenMab technology for multiplex functional screening, which focuses on monoclonal antibodies with high specificity for tumor neoantigens. Founded in 2006, Immunome is dedicated to advancing immunotherapy through its innovative approaches in antigen discovery and antibody development.

KickUp

Series A in 2019
KickUp helps professional development teams differentiate teacher support through analytics. Its SaaS-based analytics platform is designed to offer professional learning services. The analytics platform helps users customize pre-loaded goals to align with their district or region's strategic goals, pull together real-time data from surveys. They partner with K-12 organizations to coordinate professional learning efforts, improve decision-making, and ensure that great ideas translate into demonstrable outcomes in the classroom. Jeremy Rogoff, Victoria Kinzig, and Eric Krupski headquartered KickUp in Philadelphia, Pennsylvania in 2014.

Intrommune Therapeutics

Series A in 2019
Intrommune Therapeutics is a clinical-stage biotechnology company focused on developing safe and effective treatments for food allergies. The company’s Oral Mucosal Immunotherapy (OMIT) platform utilizes a specially formulated toothpaste that allows patients to safely expose their immune systems to allergenic proteins while maintaining oral hygiene. The primary product under development, INT301, targets peanut allergy, addressing a significant unmet need in a market with limited treatment options. Currently, only one FDA-approved product for food allergies exists, which requires patients to ingest peanut protein, a method that many find difficult and risky. Intrommune's innovative approach aims to provide a more accessible and manageable solution for patients and their families, reducing the fear associated with food allergies. The company is conducting a Phase 1b study for INT301, with important developmental milestones expected in the coming year.

Simply Good Jars

Seed Round in 2019
Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everyday operations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.

Ophidion

Venture Round in 2019
Ophidion is a biotechnology company that specializes in developing therapeutics for the central nervous system by delivering treatments directly to targeted sites in the brain. Utilizing a Trojan horse strategy, Ophidion exploits an endogenous receptor-mediated transport system to facilitate the intravenous delivery of small molecule drugs and biologics, including gene-silencing therapies. The company focuses on treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its platform is versatile, allowing for the delivery of various drug classes, including oligonucleotides, small interfering RNAs (siRNAs), antibodies, and peptides. Additionally, Ophidion has an advanced program aimed at addressing anxiety-related disorders, which includes a patented companion biomarker diagnostic to identify suitable patient populations for treatment.

WizeHive

Convertible Note in 2019
WizeHive, Inc. is a technology company that specializes in developing online software platforms designed to help organizations manage various processes efficiently. Founded in 2009 and based in Conshohocken, Pennsylvania, WizeHive offers a range of solutions including grants management, scholarship management, awards management, fellowship management, internship management, and accreditation management systems. These tools allow users to collect, manage, and review applications online, effectively streamlining administrative tasks. The company's flagship product, Zengine, is a cloud-based platform that enables non-technical users to create custom business applications while providing developers with the capability to enhance these applications through integrations and added functionalities. By facilitating better organization and communication among clients, WizeHive helps foundations, universities, and government agencies save time and reduce administrative costs.

Wash Cycle Laundry

Convertible Note in 2019
Wash Cycle Laundry will pick up your dirty laundry on a bike and bring it back clean tomorrow. Cleaning clothes can be a dirty business. They use eco-friendly "free and clear" laundry detergents for all their wash-and-fold, and only non-perc solvents for all their dry cleaning. Most standard dry cleaners use "PERC" in their dry cleaning process, which the State of California believes to be a carcinogen. Founded in 2010 and headquartered in Philadelphia, Pennsylvania.

Burrow

Series B in 2019
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.

Sidecar

Series C in 2019
Sidecar is an e-commerce marketing company that builds the advanced technology retailers need to optimize cross-channel online shopping campaigns. With a team of data science and e-commerce experts, our state-of-the-art machine learning engine, and a massive volume of data, Sidecar is the magic behind retail's most efficient and powerful online shopping campaigns.

ExpressCells

Series A in 2019
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers. ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.
Illumina Radiopharmaceuticals

Simply Good Jars

Pre Seed Round in 2018
Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everyday operations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.

Lia

Seed Round in 2018
LIA Diagnostics Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing innovative pregnancy test kits. Founded in 2015, the company focuses on addressing key issues associated with traditional pregnancy tests, specifically privacy, usability, and sustainability. LIA's test kits are made from eco-friendly materials, containing no plastic, and are designed to be foldable, flushable, and easy to carry. This design allows users to conduct tests discreetly and conveniently, while also minimizing confusion in test interpretation. By prioritizing sustainability and user experience, LIA Diagnostics aims to redefine the pregnancy testing process for women.

Virion Therapeutics

Series A in 2018
Virion Therapeutics, LLC is a biotechnology company focused on developing immune-based treatments for virally associated cancers and chronic viral infections. Founded in 2018 and headquartered in Newark, Delaware, the company offers innovative vaccines, ChiVax and ChiVax-gD, which aim to induce potent and sustained T cell-mediated immune responses against transformed or infected cells. These chimeric vaccine candidates have successfully completed pre-clinical testing, paving the way for clinical trials targeting diseases with significant unmet medical needs, such as HPV-induced cancers and chronic Hepatitis B infections. Virion Therapeutics combines scientific expertise with management experience to advance its immunotherapy platforms, which may ultimately improve patient outcomes in the fight against these challenging health issues.

Proscia

Series A in 2018
Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

Burrow

Series A in 2018
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.